Biopharma PEG supplies polyethylene glycol (PEG) derivatives, monodisperse PEGs, custom PEG derivative synthesis and PEGylation services worldwide, from R&D through GMP commercial quantities, for preclinical, clinical trials, and commercial products for pharma, biotech, medical devices, and diagnostics
The molecule was first identified and studied by the Sikiric research group in Croatia starting in the early 1990s, and the bulk of the preclinical evidence base comes from more than three decades of rat and rodent studies showing consistent tissue-repair, anti-inflammatory, and gastroprotective effects
Full pricing is only disclosed after completing the intake questionnaire
While correlation does not equal causation, the parallel decline of a regenerative peptide and the onset of hair thinning is biologically plausible and suggests that topical GHK-Cu supplementation could compensate for what the body no longer produces in sufficient quantities